The Interplay Between COVID-19 and Pediatric Endocrine Disorders. What have we Learned After More than Three Years of the Pandemic?

Abstract

As an increased body of COVID-19 related research is now available, it becomes apparent that the effects of COVID-19 extend beyond that of the respiratory system. Among others, the endocrine system is particularly vulnerable to perturbation from the COVID-19 infection. The present scoping review summarizes the bidirectional relationship between COVID-19 and endocrine system in children and adolescents, by describing both the possible susceptibility of children and adolescents without endocrinopathies to endocrine disorders following COVID-19 infection, but also the potential susceptibility to COVID-19 infection and severe infection, or the aggravation of endocrine dysfunction in patients with pre-existing endocrine diseases. Data suggest increased obesity and diabetes rates, as well as increased severity and frequency of diabetic ketoacidosis following COVID-19 infection. Conversely, patients with diabetes and obesity may experience a more severe course of COVID-19 infection. However, in the majority of cases, children and adolescents with well-managed and regulated endocrine disorders do not appear to be at increased risk of infection or severe infection from COVID-19. Thus, adhering to the appropriate “sick day management rules”, maintaining adequate supply of medications and supplies, keeping close contact with the therapeutic team and seeking medical help without delay when needed, are the main recommendations for a safe outcome. Additional lessons learnt during the pandemic include the risk for mental health diseases caused by children’s disrupted routine due to COVID-19 related protective measures and the importance of adopting alternative communication options, such as telehealth visits, in order to ensure uninterrupted endocrine care.

Key words

COVID-19 - endocrine - children - obesity - severity

Publication History

Received: 31 May 2022

Accepted after revision: 04 August 2023

Article published online:
06 September 2023

• References

• 1 Wan Y, Shang J, Graham R. et al. Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS coronavirus. J Virol 2020; 94: 00127-20
• 2 Hoffmann M, Kleine-Weber H, Schroeder S. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020; 181: 8
• 3 Roberts CM, Levi M, McKee M. et al. COVID-19: a complex multisystem disorder. Br J Anaesth 2020; 125: 238-242
• 4 Liu F, Long X, Zhang B. et al. ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection. Clin Gastroenterol Hepatol 2020; 18: 2128-2130.e2
• 5 Loades ME, Chatburn E, Higson-Sweeney N. et al. Rapid systematic review: the impact of social isolation and loneliness on the mental health of children and adolescents in the context of COVID-19. J Am Acad Child Adolesc Psychiatry 2020; 59: 1218-1239
• 6 Ruíz-Roso MB, de Carvalho Padilha P, Matilla-Escalante DC. et al. Changes of physical activity and ultra-processed food consumption in adolescents from different countries during Covid-19 pandemic: an observational study. Nutrients 2020; 12: 2289
• 7 Mattioli AV, Pinti M, Farinetti A. et al. Obesity risk during collective quarantine for the COVID-19 epidemic. Obes Med 2020; 20: 100263
• 8 Vogel M, Geserick M, Gausche R. et al. Age- and weight group-specific weight gain patterns in children and adolescents during the 15 years before and during the COVID-19 pandemic. Int J Obes 2022; 46: 144-152
• 9 Huizar MI, Arena R, Laddu DR. “Covibesity,” a new pandemic. Obes Med 2020; 19: 100282
• 10 Yang S, Guo B, Ao L. et al. Obesity and activity patterns before and during COVID-19 lockdown among youths in China. Clin Obes 2020; 10: 12416
• 11 Allabadi H, Dabis J, Aghabekian V. et al. Impact of COVID-19 lockdown on dietary and lifestyle behaviours among adolescents in Palestine. Dynam Hum Health 2020; 7: 2170
• 12 Adams EL, Caccavale LJ, Smith D. et al. Food Insecurity, the Home Food Environment, and Parent Feeding Practices in the Era of COVID-19. Obesity 2020; 28: 2056-2063
• 13 Sidor A, Rzymski P. Dietary Choices and Habits during COVID-19 Lockdown: Experience from Poland. Nutrients 2020; 12: 1657
• 14 Di Renzo L, Gualtieri P, Pivari F. et al. Eating habits and lifestyle changes during COVID-19 lockdown: An Italian survey. J Transl Med 2020; 18: 229
• 15 Han J, Chung Y, Chung I. et al. Impact of the COVID-19 pandemic on seasonal variations in childhood and adolescent growth: experience of pediatric endocrine clinics. Children 2021; 8: 404
• 16 Brazendale K, Beets MW, Weaver RG. et al. Understanding differences between summer vs. school obesogenic behaviors of children: the structured days hypothesis. Int J Behav Nutr Phys Act 2017; 14: 100
• 17 Rajmil L, Medina-Bustos A, Fernández de Sanmamed MJ. et al. Impact of the economic crisis on children’s health in Catalonia: a before-after approach. BMJ Open 2013; 3: e003286
• 18 Zheng W, Yokomichi H, Matsubara H. et al. Longitudinal changes in body mass index of children affected by the Great East Japan Earthquake. Int J Obes (Lond) 2017; 41: 606-612
• 19 Malhotra S, Sivasubramanian R, Singhal V. Adult obesity and its complications: a pediatric disease?. Curr Opin Endocrinol Diabetes Obes 2021; 28: 46-54
• 20 Ribeiro KD, Garcia LR, Dametto JF. et al. COVID-19 and nutrition: the need for initiatives to promote healthy eating and prevent obesity in childhood. Child Obes 2020; 16: 235-237
• 21 Garg S, Kim L, Whitaker M. et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 – COVID-NET, 14 States, March 1–30, 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 458-464
• 22 HealthLDo. Louisiana Department of Health Updates for 3/27/2020 Online: ldh.la.gov; 2020 cited Louisiana Department of Health. Available from http://ldh.la.gov/index.cfm/newsroom/detail/5517
• 23 Prevention CfDCa. People who are at higher risk for severe illness. Online; 2020 March 26, 2020
• 24 Tripathi S, Christison AL, Levy E. et al. Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry Investigator Group. The impact of obesity on disease severity and outcomes among hospitalized children with COVID-19. Hosp Pediatr 2021; 11: 297-316
• 25 Ortiz-Pinto MA, de Miguel-Garcia S, Ortiz-Marron H. et al. Childhood obesity and risk of SARS-CoV-2 infection. Int J Obes 2022; 46: 1155-1159
• 26 Daryabor G, Kabelitz D, Kalantar K. An update on immune dysregulation in obesity-related insulin resistance. Scand J Immunol 2019; 89: e12747
• 27 Luo X, Zhou W, Yan X. et al. Prognostic value of C-reactive protein in patients with COVID-19. MedRxiv 2020; DOI: 10.1101/2020.03.21.20040360.
• 28 Trim W, Turner JE, Thompson D. Parallels in immunometabolic adipose tissue dysfunction with ageing and obesity. Front Immunol 2018; 9: 169
• 29 Stengel A, Goebel-Stengel M, Teuffel P. et al. Obese patients have higher circulating protein levels of dipeptidyl peptidase IV. Peptides 2014; 61: 75-82
• 30 Stein PD, Beemath A, Olson RE. Obesity as a risk factor invenous thromboembolism. Am J Med 2005; 118: 978-980
• 31 Unsworth R, Wallace S, Oliver NS. et al. New-onset type 1 diabetes in children during COVID-19: multicenter regional findings in the U.K. Diabetes Care 2020; 43: 170-171
• 32 Modarelli R, Sarah S, Ramaker ME. et al. Pediatric diabetes on the rise: Trends in incident diabetes during the COVID-19 pandemic. J Endocr Soc 2022; 6: bvac024
• 33 Ayoubkhani D, Khunti K, Nafilyan V. et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ 2021; 372: n693
• 34 Petitti DB, Klingensmith GJ, Bell RA. et al. SEARCH for diabetes in youth study group. glycemic control in youth with diabetes: the SEARCH for diabetes in Youth Study. J Pediatr 2009; 155: 668-672.e1
• 35 Güemes M, Storch-de-Gracia P, Vinagre Enriquez S. et al. Severity in pediatric type 1 diabetes mellitus debut during the COVID-19 pandemic. J Pediatr Endocrinol Metab 2020; 33: 1601-1603
• 36 Kostopoulou E, Eliopoulou MI, Rojas Gil AP. et al. Impact of COVID-19 on new-onset type 1 diabetes mellitus – a one-year prospective study. Eur Rev Med Pharmacol Sci 2021; 25: 5928-5935
• 37 Kamrath C, Mönkemöller K, Biester T. et al. Ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the COVID-19 pandemic in Germany. JAMA 2020; 324: 801-804
• 38 Naguib MN, Raymond JK, Vidmar AP. New onset diabetes with diabetic ketoacidosis in a child with multisystem inflammatory syndrome due to COVID-19. J Pediatr Endocrinol Metab 2021; 34: 147-150
• 39 Elbarbary NC, dos Santos TJ, de Beaufort C. et al. The challenges of managing pediatric diabetes and other endocrine disorders during the COVID-19 pandemic: results from an international cross-sectional electronic survey. Front Endocrinol 2021; DOI: 10.1389/fen-do.2021.735554.
• 40 Hollstein T, Schulte DM, Schultz J. et al. Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report. Nat Metab 2020; 2: 1021-1024
• 41 Rubino F, Amiel SA, Zimmet P. et al. New-onset diabetes in Covid-19. N Engl J Med 2020; 383: 789-790
• 42 Steenblock C, Richter S, Berger I. et al. Viral infiltration of pancreatic islets in patients with COVID-19. Nat Commun 2021; 12: 3534
• 43 Coate KC, Cha J, Shrestha S. et al. HPAP Consortium. SARS- CoV-2 cell entry factors ACE2 and TMPRSS2 are expressed in the microvasculature and ducts of human pancreas but are not enriched in β cells. Cell Metab 2020; 32: 1028-1040.e4
• 44 Fignani D, Licata G, Brusco N. et al. SARS-CoV-2 receptor angiotensin I-converting enzyme type 2 (ACE2) is expressed in human pancreatic β-cells and in the human pancreas microvasculature. Front Endocrinol (Lausanne) 2020; 11: 596898
• 45 Bronson SC. Practical scenarios and day-to-day challenges in the management of diabetes in COVID-19 – dealing with the ‘double trouble’. Prim Care Diabetes 2021; 15: 737-739
• 46 Armeni E, Aziz U, Qamar S. et al. Protracted ketonaemia in hyperglycaemic emergencies in COVID-19: a retrospective case series. Lancet Diabetes Endocrinol 2020; 8: 660-663
• 47 https://www.cdc.gov/mmwr/volumes/70/wr/mm7037a3.htm?s_cid=mm7037a3_w)
• 48 Regelmann MO, Conroy R, Gourgari E. et al. on behalf of the PES Drug and Therapeutics Committee and Practice Management Committee. Pediatric endocrinology in the time of COVID-19: considerations for the rapid implementation of telemedicine and management of pediatric endocrine conditions. Horm Res Paediatr 2020; 93: 343-350
• 49 Jones MS, Goley AL, Alexander BE. et al. Inpatient transition to virtual care during COVID19 pandemic. Diabetes Technol Ther 2020; 22: 444-448
• 50 Shafiee A, Teymouri Athar MM, Nassar M. et al. Comparison of COVID-19 outcomes in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis. Diabetes Metab Syndr 2022; 16: 102512
• 51 Alfayez OM, Aldmasi KS, Alruwais NH. et al. Incidence of diabetic ketoacidosis among pediatrics with type 1 diabetes prior to and during COVID-19 pandemic: A meta-Analysis of observational studies. Front Endocrinol 2022; DOI: 10.3389/fendo.2022.856958.
• 52 Barron E, Bakhai C, Kar P. et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol 2020; 8: 813-822
• 53 Muniyappa R, Gubbi S. COVID-19 pandemic, coronaviruses, and diabetes mellitus. Am J Physiol Endocrinol Metab 2020; 318: 736-741
• 54 Roca-Ho H, Riera M, Palau V. et al. Characterization of ACE and ACE2 expression within different organs of the NOD mouse. Int J Mol Sci 2017; 18: 563
• 55 Geerlings SE, Hoepelman AIM. Immune dysfunction in patients with diabetes mellitus [DM]. FEMS Immunol Med Microbiol 1999; 26: 259-265
• 56 Varin EM, Mulvihill EE, Beaudry JL. et al. Circulating levels of soluble dipeptidyl peptidase-4 are dissociated from inflammation and induced by enzymatic DPP4 inhibition. Cell Metab 2019; 29: 5
• 57 Raj VS, Mou H, Smits SL. et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 2013; 495: 251-254
• 58 Ryskjaer J, Deacon CF, Carr RD. et al. Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake. Eur J Endocrinol 2006; 155: 485-493
• 59 Mehta P, Mc Auley DF, Brown M. et al. COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet 2020; 395: 1033-1034
• 60 De Guzman KR, Snoswell CL, Taylor ML. et al. A systematic review of pediatric telediabetes service models. Diabetes Technol Ther 2020; 22: 623-638
• 61 Shah N, Karguppikar M, Bhor S. et al. Impact of lockdown for COVID-19 pandemic in Indian children and youth with type 1 diabetes from different socio-economic classes. J Pediatr Endocrinol Metab 2021; 34: 217-223
• 62 Li MY, Li L, Zhang Y. et al. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty 2020; 9: 45
• 63 Yao XH, Li TY, HeZ C. et al. A pathological report of three COVID-19 cases by minimally invasive autopsies. Zhonghua Bing Li Xue Za Zhi 2020; 49: 009
• 64 Chen W, Tian Y, Li Z. et al. Potential interaction between SARS-CoV-2 and thyroid: A review. Endocrinology 2021; 162: bqab004
• 65 Lui DTW, Ho C, Wing L. et al. Role of non-thyroidal illness syndrome in predicting adverse outcomes in COVID-19 patients predominantly of mild-moderate severity. Clin Endocrinol (Oxf) 2021; 95: 469-477
• 66 Muller I, Cannavaro D, Dazzi D. et al. SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes Endocrinol 2020; 8: 739-741
• 67 Guan WJ, Ni ZY, Hu Y. et al. Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med 2020; 382: 1708-1720
• 68 Calcaterra V, Biganzoli G, Dilillo D. et al. Non-thyroidal illness syndrome and SARS-CoV-2-associated multisystem inflammatory syndrome in children. J Endocrinol Invest 2022; 45: 199-208
• 69 Van den Berghe G. Non-thyroidal illness in the ICU: a syndrome with different faces. Thyroid 2014; 24: 1456-1465
• 70 Khoo B, Tan T, Clarke SA. et al. Thyroid function before, during, and after COVID-19. J Clin Endocrinol Metab 2021; 106: 803-811
• 71 Boelaert K, Visser WE, Taylor PN. et al. Endocrinology in the time of Covid-19: management of hyperthyroidism and hypothyroidism. Eur J Endocrinol 2020; 183: 33-39
• 72 Banull NR, Reich PJ, Anka C. et al. Association between endocrine edisorders and severe COVID-19 disease in pediatric patients. Horm Res Paediatr 2022; DOI: 10.1159/000524595.
• 73 Taylor PN, Zhang L, Lee RWJ. et al. New insights into the pathogenesis and nonsurgical management of Graves orbitopathy. Nat Rev Endocrinol 2020; 16: 104-116
• 74 Chen W, Tian Y, Li Z. et al. Potential interaction between SARS-CoV-2 and thyroid: a review. Endocrinology 2021; 162: bqab004
• 75 Ross DS, Burch HB, Cooper DS. et al. 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 2016; 26: 1343-1421
• 76 Zhou F, Yu T, Du R. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054-1062
• 77 Isidori AM, Pofi R, Hasenmajer V. et al. Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection. Lancet Diabetes Endocrinol 2020; DOI: 10.1016/S2213-8587(20)30149-2.
• 78 Annane D, Pastores SM, Rochwerg B. et al. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Crit Care Med 2017; 45: 2078-2088
• 79 Gonen MS, De Bellis A, Durcan E. et al. Assessment of neuroendocrine changes and hypothalamo-pituitary autoimmunity in patients with COVID-19. Horm Metab Res 2022; 54: 153-161
• 80 Clarke SA, Abbara A, Dhillo WS. Impact of COVID-19 on the endocrine system: a mini review. Endocrinology 2022; 163: 1-20
• 81 Tan T, Khoo B, Mills EG. et al. Association between high serum total cortisol concentrations and mortality from COVID-19. Lancet Diabetes Endocrinol 2020; 8: 659-660
• 82 ARC Study Group. Mandal S, Barnett J, Brill SE. et al. ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax 2021; 76: 396-398
• 83 Bancos I, Hazeldine J, Chortis V. et al. Primary adrenal insufficiency is associated with impaired natural killer cell function: a potential link to increased mortality. Eur J Endocrinol 2017; 176: 471-480
• 84 Endocrinology Sf. (webpage). Online 2020 (updated March 11, 2020; cited 2020 March 15). Advice Statement. Available from https://www.endocrinology.org/news/item/14050/Coronavirus-advice-statement-for-patients-with-adrenal %2fpituitary-insufficiency
• 85 Wiebke A, Stephanie EB, Simon HSP. et al. Endocrinology in the time of COVID-19: management of adrenal insufficiency. Eur J Endocrinol 2020; DOI: 10.1530/EJE-20-0361.
• 86 Alsulaimani SA, Mazi A, Bawazier M. et al. Effect of the COVID-19 pandemic on treatment adherence among children with congenital adrenal hyperplasia. Cureus 2022; 14: 27762
• 87 John NP, Lynnette N, Martin R. et al. Endocrinology in the time of COVID-19: Management of Cushing’s syndrome. Eur J Endocrinol 2020; DOI: 10.1530/EJE-20-0352.
• 88 Temiz MZ, Dincer MM, Hacibey I. et al. Investigation of SARS-CoV-2 in semen samples and the effects of COVID-19 on male sexual health by using semen analysis and serum male hormone profile: a cross-sectional, pilot study. Andrologia 2021; 53: e13912
• 89 Woolf PD, Hamill RW, McDonald JV. et al. Transient hypogonadotropic hypogonadism caused by critical illness. J Clin Endocrinol Metab 1985; 60: 444-450
• 90 Dhindsa S, Zhang N, McPhaul MJ. et al. Association of circulating sex hormones with inflammation and disease severity in patients with COVID-19. JAMA Netw Open 2021; 1-15
• 91 Mehta OP, Bhandari P, Raut A. et al. Coronavirus disease (COVID-19): comprehensive review of clinical presentation. Front Public Health 2021; 8: 582932
• 92 Davis HE, Assaf GS, McCorkell L. et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalmedicine 2021; 38: 101019
• 93 Street ME, Ponzi D, Renati R. et al. Precocious puberty under stressful conditions: new understanding and isnights from the lessons learnt from international adoptions and the COVID-19 pandemic. Front Endocrinol 2023; 14: 1149417
• 94 Street ME, Sartori C, Catellani C. et al. Precocious puberty and Covid-19 into perspective: potential increased frequency, possible causes, and a potential emergency to be addressed. Front Pediatr 2021; 9: 734899
• 95 Baby M, Ilkowitz J, Cheema Brar P. Impacts of the COVID-19 pandemic on the diagnosis of idiopathic central precocious puberty in pediatric females in New York City. J Pediatr Endocrinol Metab 2023; 36: 517-522
• 96 Peinkhofer M, Bossini B, Penco A. et al. Reduction in pediatric growth hormone deficiency and increase in central precocious puberty diagnoses during COVID 19 pandemics. Ital J Pediatr 2022; 48: 49
• 97 LaRoy M, McGuire M. Pituitary apoplexy in the setting of COVID-19 infection. Am J Emerg Med 2021; 47: 329.e1-329.e2
• 98 European Society for Paediatric Endocrinology (ESPE). Coronavirus disease (COVID-19) information for children and adolescents living with endocrine conditions, including type 1 diabetes mellitus. Internet, Cited 23 Mar 2020. Available at: https://www.eurospe.org/news/item/14064/COVID-19-information-for-children-and-adolescents-living-with-endocrine-conditions-including-type-1-diabetes-mellitus)
• 99 Liamis G, Milionis HJ, Elisaf M. Hyponatremia in patients with infectious diseases. J Infect 2011; 63: 327-335
• 100 Christ-Crain M, Hoorn EJ, Sherlock M. et al. Endocrinology in the time of COVID-19: management of diabetes insipidus and hyponatraemia. Eur J Endocrinol 2020; EJE-20-0338
• 101 Booth CM, Matukas LM, Tomlinson GA. et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003; 289: 2801-2809
• 102 Di Filippo L, Formenti AM, Rovere-Querini P. et al. Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19. Endocrine 2020; 68: 475-478
• 103 Liu J, Han P, Wu J. et al. Prevalence and predictive value of hypocalcemia in severe COVID-19 patients. J Infect Public Health 2020; 13: 1224-1228
• 104 Sun JK, Zhang WH, Zou L. et al. Serum calcium as a biomarker of clinical severity and prognosis in patients with coronavirus disease 2019. Aging (Albany N. Y.) 2020; 12: 11287-11295
• 105 El-Kurdi B, Khatua B, Rood C. et al. Liptoxicity in COVID-19 study group. mortality from Coronavirus disease 2019 increases with unsaturated fat and may be reduced by early calcium and albumin supplementation. Gastroenterology 2020; 159: 1015-1018.e4
• 106 De Oliveira C, Khatua B, Noel P. et al. Pancreatic triglyceride lipase mediates lipotoxic systemic inflammation. J Clin Investig 2020; 130: 1931-1947
• 107 Khatua B, Yaron JR, El-Kurdi B. et al. Ringer’s lactate prevents early organ failure by providing extracellular calcium. J Clin Med 2020; 9: 263
• 108 Elkattawy S, Alyacoub R, Ayad S. et al. A novel case of hypoparathyroidism secondary to SARS-CoV-2 infection. Cureus 2020; 12: e10097
• 109 Georgakopoulou VE, Avramopoulos P, Papalexis P. et al. COVID-19 induced hypoparathyroidism: a case report. Exp Ther Med 2022; 23: 346
• 110 Alshukairi AN, Doar H, Al-Sagheir A. et al. Outcome of COVID-19 in patients with osteogenesis imperfect: a retrospective multicenter study in Saudi Arabia. Front Endocrinol 2022; 12: 800376
• 111 Brizola E, Adami G, Baroncelli GI. et al. Providing high-quality care remotely to patients with rare bone diseases during COVID-19 pandemic. Orphanet J Rare Dis 2020; 15: 228
• 112 Erat T, Atar M, Kontbay T. Transient benign hyperphosphatasemia due to COVID-19: the first case report. J Pediatr Endocrinol Metab 2021; 34: 385-387
• 113 Kiess W, Tanja P, Anne J. et al. Covid19 pandemic and pediatric endocrinology and metabolism – are we through with it?. J Pediatr Endocrinol Metab 2021; 34: 535-537
• 114 Duffus SH, Cooper KL, Agans RP. et al. Mental health and behavioral screening in pediatric type 1 diabetes. Diabetes Spectr 2019; 32: 171-175
• 115 Ho C, Ng NBH, Lee YS. Caring for pediatric patients with diabetes amidst the Coronavirus disease 2019 storm. J Pediatr 2020; 223: 186-187
• 116 Dayal D. We urgently need guidelines for managing COVID-19 in children with comorbidities. Acta Paediatr 2020; 109: 1497-1498
• 117 Zachariah P, Johnson CL, Halabi KC. et al. Epidemiology, clinical features, and disease severity in patients with coronavirus disease 2019 (COVID-19) in a children’s hospital in New York city, New York. JAMA Pediatr 2020; 174: 202430
• 118 Zachurzok A, Wojcik M, Gawlik A. et al. An attempt to assess the impact of pandemic restrictions on the lifestyle, diet, and body mass index of children with endocrine diseases – preliminary results. Nutrients 2021; 14: 156
• 119 Kostopoulou E, Gkentzi D, Papasotiriou M. et al. The impact of COVID-19 on paediatric emergency department visits. A one-year retrospective study. Pediatr Res 2022; 91: 1257-1262
• 120 Cabana MD, Menard Livingston L. Will telemedicine be the blockbuster or Netflix of healthcare?. Medpage Today. 2020 Available from: https://www.medpagetoday.com/practicemanagement/telehealth/87662
• 121 Tenenbaum A, Shefer-Averbuch N, Lazar L. et al. Growth assessment of children during the COVID-19 pandemic-Can we rely on parental measurements?. Acta Paediatr 2021; 110: 3040-3045
• 122 Association AD COVID-19 from the American Diabetes Association (Online). ADA; 2020 March 2020:Webpage9. Available from https://www.diabetes.org/diabetes/treatment-care/planning-sick-days/coronavirus
• 123 Kostopoulou E, Güemes M, Shah P. COVID-19 in children and adolescents with endocrine conditions. Horm Metab Res 2020; 52: 769-774
• 124 Miller R, Ashraf AP, Gourgari E. et al. SARS-CoV-2 infection and paediatric endocrine disorders: Risks and management considerations. Endocrinol. Diabetes Metab 2021; 4: 00262